MedTrace Logo

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

NCT02194439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 415

Last updated 2021-02-26

Study results available
· View outcomes & findings →

Summary

This study is designed to collect longitudinal biological samples from patients after hematopoietic cell transplantation (HCT) cared for at multiple bone marrow transplant centers to validate biomarkers of both acute and chronic GVHD as well as for use in future unspecified research. The centers include Dana-Farber Cancer Institute and Boston's Children's Hospital, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Fred Hutchinson Cancer Research Center, Texas Children's Hospital, Children's National Medical Center, and Indiana University Simon Cancer Center.

Conditions

  • Graft-Versus-Host Disease

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Indiana University

    lead OTHER

Principal Investigators

  • Sophie Paczesny, MD, PhD · Indiana University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2019-09-30
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02194439 on ClinicalTrials.gov